We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > DS-8201

News List

Looking at the ADC Territory of Two Industry Pioneers From the DS-8201 Patent Dispute Yefenghong
January 02, 2024
A study by renowned American economist Edwin Mansfield suggests that 60% of new drugs would not be invented without patent protection, highlighting the importance of patent protection in the pharmaceutical industry today.
Daiichi to test cancer drug combo pharmatimes
September 27, 2018
Daiichi Sankyo has entered into a clinical trial collaboration agreement with a subsidiary of MSD to evaluate a potential new combination...
Daiichi Sankyo Announces Research Collaboration to Evaluate DS-8201, Keytruda americanpharmaceuticalreview
September 21, 2018
Daiichi Sankyo has entered into a clinical trial collaboration agreement with a subsidiary of Merck to evaluate the combination of Daiichi Sankyo's investigational HER2 targeting antibody drug conjugate DS-8201 and Keytruda (pembrolizumab) in HER2 express